121 Best Health Tech Startups to Watch in 2023

121 Health Tech Startups to Watch (and Work for) in 2023

Health Tech's tech sector is booming. This year’s list of the best 121 Health Tech tech startups is an eclectic mix of hyper-growth scaleups, small creative startups and everything in between.

Curated by @gonsanchezs

Health Tech 10+ employees Fast-growing

The last update was made on March 14, 2023.


Get smarter about European tech

Join 21,000+ subscribers receiving a 5-minute update on European tech every Sunday.


Get the full list of 9,200+ European tech companies

Download a carefully-curated .csv of over 9,200+ fast-growing European tech companies you can research, apply to and do business with.

Learn more
Doctolib

Doctolib is an online and mobile booking platform that helps users find doctors and make appointments.

Paris   1001 to 5000   $820 Million   $170 Million  

Accel   Eurazeo  

B2B   B2C   MARKETPLACE  

Payfit

Payfit allows small and medium enterprises to easily and quickly pay their employees.

Paris   251 to 500   $100 Million   $79 Million  

Accel   Eurazeo  

B2B   SAAS  

Alan

Alan is a digital health insurance platform with a focus on user experience with an excellent price-quality ratio health plan.

Paris   101 to 250   $140 Million   $54 Million  

Index Ventures   Lakestar   Ribbit Capital  

B2B   B2C  

Kry

Kry helps patients to make active choices about their health in partnership with public and private healthcare professionals.

Stockholm   501 to 1000   $730 Million   $150 Million  

Accel   Index Ventures   Creandum   Project A Ventures  

B2C   SAAS   MARKETPLACE  

Charm Therapeutics

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

London   1 to 10   $50 Million   $50 Million  

General Catalyst   Khosla Ventures  

B2B  

Ori Biotech

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

London   1 to 10   $39 Million   $30 Million  

Kindred Capital   Octopus Ventures   Amadeus Capital  

B2B  

Precirix

Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.

Brussels   11 to 50   $130 Million   $88 Million  

Novo A/S   Forbion Capital Partners   Gimv   HealthCap   Inkef Capital   V-Bio Ventures   BioMedPartners  

B2B  

Oviva

Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform.

London   251 to 500   $130 Million   $21 Million  

Earlybird Venture Capital   Partech Ventures   AlbionVC   Eight Roads Ventures  

B2B  

ottonova

ottonova is Germany's newest and purely digital health insurance

Munich   101 to 250   $140 Million   $66 Million  

HV Capital   Earlybird Venture Capital   btov Partners   Vorwerk Ventures  

B2B   B2C  

Lifen

Lifen is your simple and secure exchange of medical letters assistant.

Paris   11 to 50   $32 Million   $23 Million  

Daphni   Partech Ventures   Serena  

B2B   SAAS  

Splice Bio

Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University.

Barcelona   11 to 50   $59 Million   $57 Million  

New Enterprise Associates   Asabys Partners   Ysios Capital   UCB Ventures   Novartis Venture Fund  

B2B  

Acurable

Acurable develops wearable medical devices able to accurately diagnose and manage respiratory conditions at home.

London   11 to 50   $14 Million   $11 Million  

Kindred Capital   Kibo Ventures   Mundi Ventures  

B2B   B2C  

Acurable

Acurable develops wearable medical devices able to accurately diagnose and manage respiratory conditions at home.

London   11 to 50   $14 Million   $11 Million  

Kindred Capital   Kibo Ventures   Mundi Ventures  

B2B   B2C  

Cobee

Cobee is a Spanish fintech startup that develops an online platform that automates and simplifies employee benefits management.

Madrid   11 to 50   $19 Million   $420 Thousand  

Balderton Capital   Speedinvest   Notion Capital   Octopus Ventures   Target Global   Abac Nest   Sabadell Venture Capital  

B2B   SAAS  

Leyden Labs

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam   11 to 50   $190 Million   $48 Million  

SoftBank Group   GV  

B2B  

Hublo

Hublo provides software that ease healthcare professionals daily life so that they can focus on taking care of patients.

Paris   51 to 100   $26 Million   $26 Million  

Acton Capital Partners   Revaia  

B2B   SAAS  

Kheiron

We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake.

London   11 to 50   $22 Million   $22 Million  

Atomico   Hoxton Ventures   Connect Ventures   Nina Capital  

B2B  

LabGenius

LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.

London   51 to 100   $29 Million   $25 Million  

Atomico   Kindred Capital  

B2B  

NorthSea Therapeutics

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

Amsterdam   11 to 50   $150 Million   $40 Million  

Novo A/S   Sofinnova Partners   Ysios Capital   Forbion Capital Partners  

B2B  

Firstvet

FirstVet is digital veterinary platform that provides pet-owners with on-demand video consultations from qualified veterinarians.

Stockholm   51 to 100   $96 Million   $20 Million  

Creandum   Omers Ventures  

B2C   MARKETPLACE  

Automata

Automata is a biotechnology company that provides workflow automation for the life sciences industry.

London   11 to 50   $60 Million   $7.4 Million  

Local Globe   Hummingbird Ventures   Entrepreneur First   Octopus Ventures   HCVC   Latitude   Firstminute Capital   Isomer Capital   Aldea VC  

B2B  

Fresha

Fresha provides an online platform for booking beauty and wellness appointments with local businesses.

London   251 to 500   $190 Million   $20 Million  

Partech Ventures   Target Global   FJ Labs  

B2B   B2C   SAAS  

Elvie

Elvie is a British femtech company developing smarter technology for women.

London   51 to 100   $54 Million   $42 Million  

Octopus Ventures   Hiro Capital   Business Growth Fund  

B2B   B2C  

Carrick Therapeutics

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Dublin   51 to 100   $95 Million   $60 Million  

GV   Cambridge Innovation Capital  

Unmind

Unmind is a B2B mental health platform providing clinically-backed tools and training.

London   11 to 50   $63 Million   $4 Million  

EQT Ventures   Project A Ventures   Felix Capital  

B2B   SAAS  

Tubulis

Tubulis Technologies generates uniquely matched protein-drug conjugates.

Munich   11 to 50   $77 Million   $12 Million  

High-Tech Gründerfonds   Coparion   Bayern Kapital   BioMedPartners   Seventure Partners   Andera Partners  

B2B  

Glorify

Glorify is a mobile app designed to create space and structure for Christians to connect with God on a daily basis.

London   51 to 100   $85 Million   $4.6 Million  

A16Z   SoftBank Group  

B2C   FREEMIUM   SAAS  

Manual

Manual provides diagnostic tools and testing to help patients make health-related decisions.

London   11 to 50   $37 Million   $6.5 Million  

Cherry Ventures   Felix Capital   FJ Labs  

B2C  

AccuRx

Accurx is on a mission to make patients healthier and healthcare staff happier, through seamless communication.

London   101 to 250   $50 Million   $11 Million  

Atomico   Local Globe   Lakestar   Entrepreneur First   Latitude  

B2B   SAAS  

PathoQuest

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

Paris   11 to 50   $41 Million   $8.8 Million  

Eurazeo   Verve Ventures   Norgine Ventures  

B2B  

F2G

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

Manchester   251 to 500   $280 Million   $70 Million  

Novo A/S   Sofinnova Partners   Forbion Capital Partners  

B2B  

F2G

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

Manchester   251 to 500   $280 Million   $70 Million  

Novo A/S   Sofinnova Partners   Forbion Capital Partners  

B2B  

ImCheck Therapeutics

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

Marseille   11 to 50   $190 Million   $100 Million  

Earlybird Venture Capital   Eurazeo   Andera Partners   Gimv  

B2B  

ImmunOs Therapeutics

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Zürich   11 to 50   $90 Million   $74 Million  

Lightspeed Venture Partners   Gimv   BioMedPartners  

B2B  

Lifebit

Lifebit CloudOS is the intelligent genomics platform that is the industry standard for unified, secure research over distributed big data.

London     $11 Million   $7.5 Million  

Connect Ventures   Eurazeo  

B2B   SAAS  

Ouihelp

Ouihelp is a developer of an online residential assistance platform designed to help seniors in their regular activities at home.

Paris   51 to 100   $36 Million   $32 Million  

Future Positive Capital   XAnge  

B2B   B2C   MARKETPLACE  

Daye

Daye is a gynecological health company that creates products and services for vaginal treatment.

London   11 to 50   $17 Million   $5.5 Million  

Index Ventures   Khosla Ventures   Kindred Capital   Hambro Perks Ltd.  

B2C  

IRUBIS

IRUBIS is a company that specializes in mid-infrared spectroscopy for bioprocessing and biotechnological solutions.

Munich   11 to 50   $5.2 Million   $3.2 Million  

High-Tech Gründerfonds   Verve Ventures  

B2B  

Gourmey

We create sustainable cultivated meat delights for an uncompromising and conscious generation.

Paris   11 to 50   $58 Million   $200 Thousand  

Earlybird Venture Capital   Heartcore   Point Nine Capital   Air Street Capital   Partech Ventures   Keen Venture Partners   Social Starts   Thia Ventures  

B2B   B2C  

Mnemo Therapeutics

Mnemo Therapeutics specializes in biotechnology and life science.

Paris   101 to 250   $90 Million   $90 Million  

Sofinnova Partners  

B2B  

Doccla

Doccla is the virtual ward company. We are the pioneers of tech-agnostic virtual wards.

London   1 to 10   $20 Million   $3.3 Million  

General Catalyst   Speedinvest   Giant Ventures  

B2B   SAAS  

Skin Analytics

Skin Analytics uses artificial intelligence to screen for melanoma skin cancer.

London   11 to 50   $9 Million   $5.2 Million  

Hoxton Ventures  

B2B   SAAS  

Core Biogenesis

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

Paris   1 to 10   $25 Million   $3.2 Million  

Entrepreneur First   Plug and Play Spain   XAnge   Thia Ventures  

B2B  

Glofox

Glofox is an all in one management system that is powering the future of fitness

Dublin   101 to 250   $23 Million   $10 Million  

Notion Capital   Partech Ventures   Octopus Ventures  

B2B   SAAS  

Causaly

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

London   51 to 100   $33 Million   $4.8 Million  

Index Ventures  

B2B   SAAS  

Elypta

Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring

Stockholm   11 to 50   $33 Million   $6.7 Million  

Nina Capital   Norrsken VC   Industrifonden   Bonnier Ventures   Navigare Ventures  

B2B  

Rensair

Rensair is an electrical company that specializes in the fields of healthtech and electrical distribustion.

London   11 to 50   $7 Million   $7 Million  

Hoxton Ventures  

B2B  

Peptone

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

London   11 to 50   $42 Million   $2.5 Million  

Bessemer Venture Partners   Hoxton Ventures  

B2B  

Turbine

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

Budapest   11 to 50   $10 Million   $6.9 Million  

Accel   Day One Capital   Atlantic Labs  

B2B  

Noala

Noala is a listen to community so that together its creating the simplest and most effective platform for speech and language therapists.

London   11 to 50   $3.9 Million   $4 Million  

Local Globe   Cocoa VC  

B2C  

Ambler

Ambler is an intermediation platform that connects health care prescribers to ambulance companies.

Paris   1 to 10   $8.6 Million   $6.8 Million  

Kima Ventures   Partech Ventures  

B2B   MARKETPLACE  

Medbelle

Digital hospital of the future, providing elective medical procedures with a fully-digitised, personal and patient-first experience.

London   11 to 50   $7 Million   $7 Million  

Talis Capital   Cavalry Ventures Management   Signals Venture Capital   IBB Ventures  

B2C   MARKETPLACE  

Hertility Health

Hertility Health is on a mission to revolutionise the world of reproductive health.

London   11 to 50   $5.9 Million   $5.9 Million  

Local Globe  

B2B   B2C  

Biomemory

Biomemory designs a low-cost, biobased solution for storing large amounts of computer data on long DNA strands.

Paris   1 to 10   $0   $5.2 Million  

Bpifrance  

Cardior Pharmaceuticals

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

Hanover   11 to 50   $93 Million   $76 Million  

High-Tech Gründerfonds   Inkef Capital   Coparion   BioMedPartners   Hadean Ventures  

B2B  

Sonio

Sonio is an artificial intelligence for fetal ultrasound, helping practitioners analyse and diagnose congenital malformations.

Paris   11 to 50   $5.2 Million   $5.3 Million  

Elaia   OneRagtime  

B2B   SAAS  

SafeHeal

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

Paris   1 to 10   $52 Million   $48 Million  

Sofinnova Partners  

B2B  

CorWave

CorWave is a medical device company developing innovative heart pumps.

Paris   51 to 100   $81 Million   $43 Million  

Sofinnova Partners   Ysios Capital  

B2B  

SafeHeal

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

Paris   1 to 10   $52 Million   $48 Million  

Sofinnova Partners  

B2B  

ReViral

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

London   11 to 50   $120 Million   $44 Million  

Novo A/S   Andera Partners  

B2B  

CorWave

CorWave is a medical device company developing innovative heart pumps.

Paris   51 to 100   $81 Million   $43 Million  

Sofinnova Partners   Ysios Capital  

B2B  

Quell Therapeutics

Quell Therapeutics is a cell therapy company

London   101 to 250   $240 Million   $45 Million  

AlbionVC   Point72 Ventures  

B2B  

CMR Surgical

CMR Surgical is developing the next-generation surgical robotic system for minimal access surgery.

Cambridge   251 to 500   $970 Million   $240 Million  

SoftBank Group   Lightrock   Cambridge Innovation Capital  

B2B  

Charles.co

Charles helps men regain control over their daily health concerns by starting with their personal health.

Paris   1 to 10   $7.3 Million   $7.4 Million  

Speedinvest  

B2C  

Healx

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

Cambridge   51 to 100   $68 Million   $56 Million  

Atomico   Balderton Capital   btov Partners   Amadeus Capital  

B2B   SAAS  

Upstream Health

Upstream Health provides technologies and new service approaches for health and social care teams.

Sheffield   1 to 10   $0   $140 Million  

Coatue  

Mainstay Medical

Mainstay Medical is a global medical device company that is developing devices to deliver innovative therapies.

Dublin   101 to 250   $270 Million   $110 Million  

Sofinnova Partners   Fountain Healthcare Partners  

B2B  

Mainstay Medical

Mainstay Medical is a global medical device company that is developing devices to deliver innovative therapies.

Dublin   101 to 250   $270 Million   $110 Million  

Sofinnova Partners   Fountain Healthcare Partners  

B2B  

Tissium

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Paris   51 to 100   $160 Million   $43 Million  

Sofinnova Partners   Karista  

B2B  

Emergence Therapeutics

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Duisburg   1 to 10   $98 Million   $99 Million  

High-Tech Gründerfonds   Hadean Ventures  

B2B  

Tissium

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Paris   51 to 100   $160 Million   $43 Million  

Sofinnova Partners   Karista  

B2B  

Emergence Therapeutics

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Duisburg   1 to 10   $98 Million   $99 Million  

High-Tech Gründerfonds   Hadean Ventures  

B2B  

Muna Therapeutics

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

Copenhagen     $78 Million   $2.4 Million  

Novo A/S   Sofinnova Partners   VIB   V-Bio Ventures  

B2B  

Simundia

Simundia is a provider of digital coaching platform for a personalized development experience.

Paris   11 to 50   $12 Million   $2.3 Million  

Kima Ventures   FJ Labs   AXA Venture Partners   Educapital  

B2B   MARKETPLACE  

Aqemia

Drug discovery - Pharma 3.0

Paris   11 to 50   $31 Million   $1.1 Million  

Elaia   Eurazeo  

B2B  

Puraffinity

Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water

London   11 to 50   $7.4 Million   $3.6 Million  

Kindred Capital   Verve Ventures  

B2B  

Five Lives

Five Lives specializes in building the most accessible, affordable and clinically-validated brain health platform.

London   11 to 50   $3.9 Million   $3.8 Million  

Kima Ventures   Speedinvest   Tiny VC   Headline  

B2C   FREEMIUM   SAAS  

Five Lives

Five Lives specializes in building the most accessible, affordable and clinically-validated brain health platform.

London   11 to 50   $3.9 Million   $3.8 Million  

Kima Ventures   Speedinvest   Tiny VC   Headline  

B2C   FREEMIUM   SAAS  

Puraffinity

Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water

London   11 to 50   $7.4 Million   $3.6 Million  

Kindred Capital   Verve Ventures  

B2B  

Peanut

Peanut is an online platform that provides a safe space for women to connect across fertility and motherhood.

London   11 to 50   $17 Million   $5 Million  

Index Ventures   EQT Ventures   Felix Capital   Partech Ventures  

FREEMIUM  

Ben

Make benefits work for everyone, everywhere

London   11 to 50   $19 Million   $2.4 Million  

Atomico   Seedcamp   Cherry Ventures   DN Capital  

B2B   SAAS  

Lifesum

Lifesum is a Swedish digital health startup that helps clients become healthier by using applied psychology and technology.

Stockholm   11 to 50   $22 Million   $5 Million  

Balderton Capital  

SAAS  

Mindler

Mindler makes it easy to meet a psychologist - usually the same day!

Stockholm   11 to 50   $13 Million   $3 Million  

Ventech   Luminar Ventures   Schibsted Growth  

MARKETPLACE  

Lifesum

Lifesum is a Swedish digital health startup that helps clients become healthier by using applied psychology and technology.

Stockholm   11 to 50   $22 Million   $5 Million  

Balderton Capital  

SAAS  

Gleamer

Gleamer develops medical grade AI for Radiology

Paris   1 to 10   $11 Million   $8.7 Million  

Elaia   XAnge  

B2B   SAAS  

Nurx

Nurx is a digital healthcare company offering 10 services across reproductive health, at-home testing, dermatology, migraine care, and more.

San Francisco   251 to 500   $120 Million   $32 Million  

Union Square Ventures  

B2C  

Nabla

Digital care. Superpowered. Build engaging relationships with your patients through our machine learning-powered care platform.

Paris   11 to 50   $21 Million   $20 Million  

Firstminute Capital  

B2C  

HelloSelf

HelloSelf is a health and wellness platform that provides its users with digital access to therapists.

London   1 to 10   $11 Million   $7.6 Million  

Omers Ventures  

B2B   B2C   MARKETPLACE  

Sixfold Bioscience

Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.

London   11 to 50   $11 Million   $10 Million  

Y Combinator   Pi Campus  

B2B  

Lecturio

The Next Generation Learning Platform for Medicine

Leipzig   51 to 100   $58 Million   $45 Million  

HV Capital   Seventure Partners  

B2B   B2C   SAAS  

Stilla Technologies

Stilla Technologies is a Paris-based european biotechnology company.

Paris   11 to 50   $75 Million   $13 Million  

Eurazeo  

B2B  

Palta

Palta is a health and wellbeing technology company

London   501 to 1000   $140 Million   $14 Million  

Target Global   VNV Global  

B2B   B2C  

Stilla Technologies

Stilla Technologies is a Paris-based european biotechnology company.

Paris   11 to 50   $75 Million   $13 Million  

Eurazeo  

B2B  

Flo Health

Flo is an AI-powered women’s health app that supports women at every stage of their reproductive cycle.

London   251 to 500   $76 Million   $7.5 Million  

Target Global   VNV Global  

B2C   FREEMIUM  

PlusDental

PlusDental is a Berlin-based Health-Tech Startup in the area of digital dentistry.

Berlin   101 to 250   $88 Million   $35 Million  

HV Capital   Lakestar  

B2C  

HelloSelf

HelloSelf is a health and wellness platform that provides its users with digital access to therapists.

London   1 to 10   $11 Million   $7.6 Million  

Omers Ventures  

B2B   B2C   MARKETPLACE  

Vay

VAY creates software capable of professional motion analysis with any camera.

Zürich   1 to 10   $160 Thousand   $30 Million  

Creandum   Atomico   Project A Ventures   La Famiglia VC   Eurazeo   Visionaries Club   Signals Venture Capital   Investment AB Kinnevik  

B2B  

Cleo

Cleo is a benefits platform that provides personalized guidance for working families.

San Francisco   101 to 250   $81 Million   $44 Million  

Local Globe   Balderton Capital   EQT Ventures   Entrepreneur First  

B2C   FREEMIUM  

Tilak Healthcare

Tilak build a series of fun medical games to change the way we monitor chronic diseases.

Paris   11 to 50   $11 Million   $8.1 Million  

Elaia   iBionext  

B2B  

Resolve BioSciences

Resolve Biosciences is applying the power of Molecular Cartography to enable scientists to gain new insights in spatial biology.

Düsseldorf     $95 Million   $24 Million  

High-Tech Gründerfonds  

B2B   SAAS  

Tilak Healthcare

Tilak build a series of fun medical games to change the way we monitor chronic diseases.

Paris   11 to 50   $11 Million   $8.1 Million  

Elaia   iBionext  

B2B  

Vay

VAY creates software capable of professional motion analysis with any camera.

Zürich   1 to 10   $160 Thousand   $30 Million  

Creandum   Atomico   Project A Ventures   La Famiglia VC   Eurazeo   Visionaries Club   Signals Venture Capital   Investment AB Kinnevik  

B2B  

Padoa

Padoa is an occupational health software firm that develops a tool for monitoring the health of employees.

Paris   51 to 100   $120 Million   $91 Million  

B2B   SAAS  

SparingVision

SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.

Paris   1 to 10   $53 Million   $53 Million  

Ysios Capital  

B2B  

DnaNudge

dnaNUDGE aims to nudge people towards a better lifestyle based on their DNA.

London   11 to 50   $60 Million   $60 Million  

B2B  

Miracor Medical

Miracor Medical is a medical device company developing disruptive solutions to treat severe heart diseases.

  11 to 50   $100 Million   $28 Million  

Earlybird Venture Capital  

B2B  

Babylon Health

Babylon Health aims to provide accessible, affordable healthcare by combining AI with doctors.

London   1001 to 5000   $1.1 Billion   $550 Million  

VNV Global   Investment AB Kinnevik  

B2B   B2C  

Achilles Therapeutics

Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

London   101 to 250   $210 Million   $70 Million  

Forbion Capital Partners  

B2B  

Kumovis

Kumovis is a medical technology Company.

Munich   11 to 50   $6 Million   $3.9 Million  

High-Tech Gründerfonds   Solvay Ventures  

B2B  

Baseimmune

Baseimmune is a biotech startup founded to create the next generation of vaccines.

London   1 to 10   $5.7 Million   $950 Thousand  

Hoxton Ventures   Cherry Ventures   Maki.vc   Creator Fund  

B2B  

Miracor Medical

Miracor Medical is a medical device company developing disruptive solutions to treat severe heart diseases.

  11 to 50   $100 Million   $28 Million  

Earlybird Venture Capital  

B2B  

Elsa

Elsa is a platform for patient-driven research for better drugs, health, and prevention.

Stockholm   11 to 50   $8 Million   $2.3 Million  

Inventure   Norrsken VC   HealthCap  

MARKETPLACE  

HiFiBiO

HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.

Paris   101 to 250   $180 Million   $75 Million  

QantEv

Smart claims platform for augmented insurance

Paris   11 to 50   $12 Million   $1.7 Million  

Elaia   Entrepreneur First  

B2B   SAAS  

Elsa

Elsa is a platform for patient-driven research for better drugs, health, and prevention.

Stockholm   11 to 50   $8 Million   $2.3 Million  

Inventure   Norrsken VC   HealthCap  

MARKETPLACE  

Cera

Cera Care is a London-based technology-enabled home care company.

London   5001 to 10000   $410 Million   $65 Million  

Oltre Venture  

B2B   B2C  

Cuure

Cuure is a wellness technology startup that delivers personalized food supplements to everyone's doorsteps

Paris   1 to 10   $2.1 Million   $2.2 Million  

Kima Ventures   Newfund  

B2C   SAAS  

Baseimmune

Baseimmune is a biotech startup founded to create the next generation of vaccines.

London   1 to 10   $5.7 Million   $950 Thousand  

Hoxton Ventures   Cherry Ventures   Maki.vc   Creator Fund  

B2B  

Foodsteps

Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint.

London   11 to 50   $4.8 Million   $4.1 Million  

Ascension Ventures   Octopus Ventures   Metaplanet Holdings  

B2B   SAAS  

Elsa

Elsa is a platform for patient-driven research for better drugs, health, and prevention.

Stockholm   11 to 50   $8 Million   $2.3 Million  

Inventure   Norrsken VC   HealthCap  

MARKETPLACE  

MindLabs

MindLabs is the world's first live mental health platform.

London   1 to 10   $1.8 Million   $1.8 Million  

Seedcamp   Passion Capital  

B2C   FREEMIUM  

Get the full list of 9,200+ Health Tech & European tech companies

Download a carefully-curated .csv of over 9,200+ fast-growing European tech companies you can research, apply to and do business with.

  • 🏢 Company
  • 📊 Industry
  • 🌎 Location
  • 💰 Money Raised
  • 🔗 URL
  • 💼 Linkedin URL
  • 👤 Company Size
  • ➕ and more
Download for €49

⚠️ Price goes up to €99 on March 28

SOME OF OUR CLIENTS

  • Company
  • Hopin
  • Glovo
  • N26
  • Curve
  • Pipedrive
  • TIER
  • Industry
  • Events
  • Food
  • Fintech
  • Fintech
  • Sales
  • Mobility
  • Location
  • London
  • Barcelona
  • Berlin
  • London
  • Tallinn
  • Berlin
  • Raise
  • $125M
  • $169M
  • $100M
  • $59M
  • $500M
  • $250M
  • URL
  • hopin.com
  • glovo.com
  • n26.com
  • curve.com
  • pipedrive.com
  • tier.app

Explore other top startups & industries across Europe

...
Femtech Trends ♀️

The term femtech was coined by European entrepreneur Ida Tin in 2016 so it’s only natural to explore it.

...
London Startups

Forget all about Brexit. Europe's tech capital is still booming with fintech at its core.

...
Berlin Startups

In Berlin, a new startup is founded every 20 minutes. What else is there to say?